Eiger BioPharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

Late annual filing notification for FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Ameriprise Financial Inc.

Ameriprise Financial Inc.

683 Capital Management, LLC

News Filter

For the Northern District of Texas Dallas Division

For the Northern District of Texas Dallas Division

Completion of Acquisition or Disposition of Assets

Case 24-80040-Sgj11 Doc 582 Filed 08/30/24 Entered 08/30/24 15:16:15 Desc Main Document Page 1 of 12

Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness